Company news
CareDx, Inc. news in 2021
CareDx, Inc.'s news releases, calls and decks from 2021, newest first.
CareDx Enrolls First Patient in LungCare Registry Study to Measure Impact of Multimodality Assessment on Lung Transplant Patient Outcomes
December 15, 2021
CareDx Partners with the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Organization in Launching Prospective, Multi-Center Pediatric Kidney Transplant Study
December 12, 2021
CareDx The Transplant Company Surpasses 80,000 Patient Milestone
December 1, 2021
CareDx Named One of the Fastest-Growing Companies in North America on the Deloitte Technology Fast 500™ for the Third Consecutive Year
November 18, 2021
CareDx Enrolls First Patients in the Largest Digital Study in Transplant Using AlloCare to Assess Patient Outcomes
November 17, 2021
CareDx To Participate in Upcoming Conferences
November 14, 2021
CareDx Acquires MedActionPlan to Directly Support Patients with Better Adherence
November 9, 2021
University of Alabama Integrates CareDx’s TxAccess for Connection to Over 500 Community Practices
November 3, 2021
CareDx Focuses on Innovation in Transplant at ASN Kidney Week
November 2, 2021
CareDx Completes Orderly Management Transition
October 31, 2021
CareDx Reports Third Quarter 2021 Results; Increases Full Year Revenue Guidance
October 27, 2021
CareDx and Eledon Pharmaceuticals Announce Collaborative Research Agreement
October 18, 2021
CareDx to Report Third Quarter 2021 Financial Results
October 13, 2021
CareDx Extends Leadership in Multimodality Transplant Care with KidneyCare Validation Publication
September 29, 2021
CareDx Names Longtime Patient Advocate Art Torres to Board of Directors
September 14, 2021
CareDx Reports 77% Revenue Growth for Second Quarter of 2021 and Increases Full Year Revenue Guidance
July 28, 2021
CareDx Launches ACROBAT Study to Potentially Change Care Paradigm for Stem Cell Transplant Patients
July 25, 2021
CareDx Appoints Dr. Hannah Valantine to its Board of Directors
June 29, 2021
CareDx To Acquire Transplant Hero Medication Management Application
June 7, 2021
CareDx Presents Landmark KOAR-1000 Data, Demonstrating Higher 1-Year Graft Survival and Reduction in Biopsies through ARTS Surveillance
June 6, 2021
CareDx Presents Groundbreaking AlloSure® Data at the 2021 American Transplant Congress
June 3, 2021
CareDx Starts Enrollment in MAPLE, a Multi-modal, Multi-center, Prospective Study of LiverCare
May 31, 2021
CareDx Announces Strategic Minority Investment in Miromatrix
May 27, 2021
CareDx Reports First Quarter 2021 Results
May 4, 2021
CareDx to Report First Quarter 2021 Financial Results
April 20, 2021
CareDx Announces New HLA Typing Service Offering for Research Purposes
April 7, 2021
CareDx Enhances Leadership Team with Key Appointments
March 30, 2021
CareDx Strengthens Bioinformatics Capabilities with Acquisition of BFS Molecular
March 16, 2021
CareDx Names Ankur Dhingra as New Chief Financial Officer
March 10, 2021
CareDx Expands into the Pre-Transplant Kidney Space through TX Connect
February 24, 2021
CareDx Reports Fourth Quarter and Full Year 2020 Results
February 23, 2021
CareDx to Report Fourth Quarter and Full Year 2020 Financial Results
February 11, 2021
CareDx Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 10, 2021
CareDx Announces Closing of Public Offering of Common Stock
January 24, 2021
CareDx Announces Pricing of Public Offering of Common Stock
January 19, 2021
CareDx Announces Proposed Public Offering of Common Stock
January 18, 2021
CareDx Reports Preliminary Fourth Quarter and Full Year 2020 Results
January 10, 2021
CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers
January 7, 2021
CareDx Announces AlloID and Exclusive Partnership with IDbyDNA
January 6, 2021
CareDx’s AlloSeq HCT Wins Tender for French Stem Cell Transplant Patient Surveillance
January 3, 2021